Sideritis scardica Griseb. (ironwort, mountain tea), an endemic plant of the Balkan Peninsula, has been used in traditional medicine in the treatment of gastrointestinal complaints, inflammation, and rheumatic disorders. This study aimed to evaluate its gastroprotective and anti-inflammatory activities. Besides, continuously increasing interest in assessing the role of the plant active constituents preventing the risk of cancer was a reason to make a detailed examination of the investigated ethanol, diethyl ether, ethyl acetate, and n-butanol extracts regarding cytotoxicity. Oral administration of the investigated extracts caused a dose-dependent anti-inflammatory effect in a model of carrageenan-induced rat paw edema. Gastroprotective activity of the extracts was investigated using an ethanol-induced acute stress ulcer in rats. The cytotoxic activity of plant extracts was assessed on PBMC, B16, and HL-60 cells and compared to the cytotoxicity of phenolic compounds identified in extracts. Apoptotic and necrotic cell death were analyzed by double staining with fluoresceinisothiocyanate (FITC)-conjugated annexin V and PI. The developed HPLC method enabled qualitative fingerprint analysis of phenolic compounds in the investigated extracts. Compared to the effect of the positive control, the anti-inflammatory drug indomethacine (4 mg/kg), which produced a 50 % decrease in inflammation, diethyl ether and n-butanol extracts exhibited about the same effect in doses of 200 and 100 mg/kg (53.6 and 48.7 %; 48.4 and 49.9 %, respectively). All investigated extracts produced dose-dependent gastroprotective activity with the efficacy comparable to that of the reference drug ranitidine. The diethyl ether extract showed significant dose-dependent cytotoxicity on B16 cells and HL-60 cells, decreasing cell growth to 51.3 % and 77.5 % of control, respectively, when used at 100 µg/mL. It seems that phenolic compounds (apigenin, luteolin, and their corresponding glycosides) are responsible for the diethyl ether extract cytotoxic effect. It also appears that induction of oxidative stress might be involved in its cytotoxicity, since B16 and HL-60 cells increased their ROS production in response to treatment with diethyl ether extract. Neither of the tested extracts nor any phenolic compounds showed significant cytotoxic effect to human PBMC. These results demonstrated the potent anti-inflammatory and gastroprotective activities, as well as the promising cytotoxicity.
1
Lui Z, Tao X, Zhang C, Lu Y, Wei D.
Protective effects of hyperoside (Quercetin-3-O-galactoside) to PC12 cells against cytotoxicity induced by hydrogen peroxide and tert-butyl hydro-peroxide.
Biomed Pharmacother.
2005;
59
481-490
2
Basile A, Senatore F, Gargano R, Sorbo S, Del Pezzo M, Lavitola A, Ritieni A, Bruno M, Spatuzzi D, Rigano D, Vuotto M L.
Antibacterial and antioxidant activities in Sideritis italica (Miller) Greuter et Burdet essential oils.
J Ethnopharmacol.
2006;
107
240-248
4
Küpeli E, Şahin F P, Çalış I, Yeşilada E, Ezer N.
Phenolic compounds of Sideritis ozturkii and their in vivo anti-inflammatory and antinociceptive activities.
J Ethnopharmacol.
2007;
118
356-360
5
Aboutabl E A, Nassar M I, Elsakhawy F M, Maklad Y A, Osman A F, El-Khrisy E A M.
Phytochemical and pharmacological studies on Sideritis taurica Stephan ex Wild.
J Ethnopharmacol.
2002;
82
177-184
6
Hernàndez-Pérez M, Rabanal R M.
Evaluation of the antinflammatory and analgesic activity of Sideritis canariensis var. pannosa in mice.
J Ethnopharmacol.
2002;
81
43-47
7
Navarro A, de Las Heras B, Villar A.
Anti-inflammatory and immunomodulating properties of a sterol fraction from Sideitis foetens Clem.
Biol Pharm Bull.
2001;
24
470-473
8
de las Heras B, Navarro A, Díaz-Guerra M J, Bermejo P, Castrillo A, Boscá L, Villar A.
Inhibition of NOS-2 expression in macrophages through the inactivation of NF-kB by andalusol.
Br J Pharmacol.
1999;
28
605-612
9
Güvenç A, Okada Y, Küpeli Akkol E, Duman H, Okuyama T, Çalıs I.
Investigations of anti-inflammatory, antinociceptive, antioxidant and aldose reductase inhibitory activities of phenolic compounds from Sideritis brevibracteata.
Food Chem.
2010;
118
686-692
10
Demirtas I, Sahin A, Ayhan B, Tekin S, Telci I.
Antiproliferative effects of the methanolic extracts of Sideritis libanotica Labill. subsp. linearis.
Rec Nat Prod.
2009;
3
104-109
11
Ertaş A, Öztürk M, Boga B, Topçu G.
Antioxidant and anticholinesterase activity evaluation of ent-kaurane diterpenoids from Sideritis arguta.
J Nat Prod.
2009;
72
500-502
13
Plioukas M, Termentzi A, Gabrieli C, Zervou M, Kefalas P, Kokkalou E.
Novel acylflavones from Sideritis syriaca ssp. syriaca.
Food Chem.
2010;
123
1136-1141
14
Petreska J, Stefova M, Ferreres F, Moreno D A, Thomas-Barberan F A, Stefkov G, Kulevanova S, Gil-Izquiredo A.
Potential bioactive phenolics of Macedonian Sideritis species used for medicinal “Mountain tea”.
Food Chem.
2011;
125
13-20
15
Alipieva K I, Kostadinova E P, Evstatieva L N, Stefova M, Bankova V S.
An iridoid and a flavonoid from Sideritis lanata L.
Fitoterapia.
2009;
80
51-53
19
Koleva I, Linssen J P H, van Beek T A, Evstatieva L N, Kortenska V, Handjieva N.
Antioxidant activity screening of extracts from Sideritis species (Labiatae) grown in Bulgaria.
J Sci Food Agric.
2003;
83
809-819
20
Velioglu Y S, Mazza Gao L, Oomah B D.
Antioxidant activity and total phenolics in selected fruits, vegetables, and grain products.
J Agric Food Chem.
1998;
46
4113-4117
21 Council of Europe .Determinations of tannins in herbal drugs. European Pharmacopoeia 6.0, edition no. 6, Volume 1 Strasbourg: Council of Europe; 2004: 255
23
Oyanagui Y, Sato S.
Inhibition by nilvadipine of ischemic and carrageenan paw oedema as well as of superoxide radical production from neutrophils and xanthine oxidase.
Drug Res.
1991;
41
469-474
24
Adami E, Marazzi-Uberti E, Turba C.
Pharmacological research on gefarnate, a new synthetic isoprenoid with an anti-ulcer action.
Arch Int Pharmacodyn Ther.
1964;
58
1780-1783
26
Mijatovic S, Maksimovic-Ivanic D, Radovic J, Miljkovic D, Harhaji L, Vuckovic O, Stosic-Grujicic S, Mostarica Stojkovic M, Trajkovic V.
Anti-glioma action of aloe emodin: the role of ERK inhibition.
Cell Mol Life Sci.
2005;
62
589-598
28
Özkan G, Sagdiç O, Özcan M, Özçelik H, Ünver A.
Antioxidant and antibacterial activities of Turkish endemic Sideritis extracts.
Grasas Aceites.
2005;
56
16-20
29
Tunalier Z, Kosar M, Ozturk N, Baser K H C, Duman H, Kirimer N.
Antioxidant properties and phenolic composition of Sideritis species.
Chem Nat Comp.
2004;
40
206-210
30
Spencer J, Mohsen M, Rice-Evans C.
Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity.
Arch Biochem Biophys.
2004;
423
148-161
31
Rice-Evans C A, Miller N J, Paganga G.
Structure-antioxidant activity relationships of flavonoids and phenolic acids.
Free Radic Biol Med.
1996;
20
933-956
32
Maleki N, Garjani A, Nazemiyeh H, Nilfouroushan N, Eftekhar Sadat A T, Allameh Z, Hasannia N.
Potent anti-inflammatory activities of hydroalcoholic extract from aerial parts of Stachys inflata in rats.
J Ethnopharmacol.
2001;
75
213-218
35
Caltagirone S, Rossi C, Poggi A, Ranelletti F O, Natali P G, Brunetti M, Aiello F B, Piantelli M.
Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential.
Int J Cancer.
2000;
87
595-600
36
Fiers W, Beyaert R, Declercq W, Vandenabeele P.
More than one way to die: apoptosis, necrosis and reactive oxygen damage.
Oncogene.
1999;
18
7719-7730
37
Chen D, Chen M S, Cui Q C, Yang H, Dou Q P.
Structure-proteasome-inhibitory activity relationships of dietary flavonoids in human cancer cells.
Front Biosci.
2007;
12
1935-1945
38
Abaza L, Talorete T P, Yamada P, Kurita Y, Zarrouk M, Isoda H.
Induction of growth inhibition and differentiation of human leukemia HL-60 cells by a Tunisian gerboui olive leaf extract.
Biosci Biotechnol Biochem.
2007;
71
1306-1312
39
Hou D X, Kumamoto T.
Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling.
Antioxid Redox Signal.
2010;
13
691-719
40
Sauter B, Albert M L, Francisco L, Larsson M, Somersan S, Bhardwaj N.
Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells.
J Exp Med.
2000;
191
423-434
